Menu Search
Equities

Upexi Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
7TQ0:FRA

Upexi Inc

Actions
  • Price (EUR)0.68
  • Today's Change0.09 / 15.25%
  • Shares traded160.00
  • 1 Year change--
  • Beta-0.3217
Data delayed at least 15 minutes, as of Feb 16 2026 15:25 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Upexi, Inc. is a solana-focused treasury company. The Company is a brand owner specializing in the development, manufacturing and distribution of consumer products with diversification into the cryptocurrency space. The Company’s brands include Lucky Tail, PRAX, and Cure Mushrooms. Lucky Tail is a pet care product brand that provides products from grooming tools to nutritional products. Cure Mushrooms is a full line of medicinal mushroom products, designed by effect for consumers, which offers mushroom extracts in tinctures and gummies. PRAX is a full line of medicinal mushroom products, designed by effect for consumers, which are cultivated, extracted, and produced in the United States. Its products are distributed in the United States of America and internationally through multiple entities and managed through locations in Florida.

  • Revenue in USD (TTM)20.69m
  • Net income in USD54.69m
  • Incorporated2018
  • Employees59.00
  • Location
    Upexi Inc3030 Rocky Point Drive, Suite 420TAMPA 33607United StatesUSA
  • Phone+1 (701) 353-5425
  • Websitehttps://upexi.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.